QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AUTL

QT64Autolus Therapeutics plc
NASDAQ·Healthcare·Biotechnology·UK
Latest market price
1.51
-0.02-1.31%
OverviewShort InterestFilings
AUTLQT64Autolus Therapeutics plc·NASDAQ
OverviewShort InterestFilings
1.51-1.31%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.09
Insider Own-
Shs Outstand266.16M
Perf Week-3.21%
Market Cap407.20MForward P/E-EPS next Y-0.63Insider Trans-Shs Float-Perf Month-7.36%
Enterprise Value356.23MPEG0.06EPS next Q-0.27Inst Own-Short Float-Perf Quarter5.59%
Income-288826412.00P/S4.40EPS this Y18.48%Inst Trans-Short Ratio-Perf Half Y-5.63%
Sales92.59MP/B3.74EPS next Y28.68%ROA-54.80%Short Interest-Perf YTD-24.12%
Book/sh0.41P/C-EPS next 5Y-ROE-128.53%52W High2.70 -44.07%Perf Year-25.62%
Cash/sh0.86P/FCF-EPS past 3/5Y-ROIC-56.74%52W Low1.18 27.97%Perf 3Y-
Dividend Est.-EV/EBITDA-1.54Sales past 3/5Y133.11% 106.99%Gross Margin-11.19%Volatility5.10% 4.78%Perf 5Y-
Dividend TTM-EV/Sales3.85EPS Y/Y TTM-25.29%Oper. Margin-285.90%ATR (14)0.12Perf 10Y-
Dividend Ex-Date-Quick Ratio5.28Sales Y/Y TTM820.00%Profit Margin-311.95%RSI (14)44.90Recom2.21
Dividend Gr. 3/5Y-Current Ratio5.80EPS Q/Q-3.85%SMA20-6.50%Beta1.91Target Price8.87
Payout0.00%Debt/Eq0.73Sales Q/Q188.89%SMA50-4.49%Rel Volume0.58Prev Close1.53
Employees647LT Debt/Eq1.89EarningsAug 11SMA200-1.18%Avg Volume1.47MPrice1.51
IPO DateJun 22, 2018Option/ShortNo / YesEPS/Sales Surpr.6.90% 0.00%Net Debt/EBITDA0.22Volume843,801Change-1.31%
Analyst Ratings
DateActionAnalystRatingTarget
Nov-18-24UpgradeGoldman SachsNeutral → Buy$7.60
Nov-15-24UpgradeRedburn AtlanticNeutral → Buy
May-20-24ReiteratedWells FargoOverweight$8.00
Apr-08-24ReiteratedTruist Financial$10 → $11
Mar-15-24ReiteratedTruist Financial$10
Mar-10-21DowngradeRedburnBuy → Neutral
Mar-10-21DowngradeRedburn PartnersBuy → Neutral
Mar-09-21DowngradeRedburnBuy → Neutral
Jan-29-21DowngradeJP MorganOverweight → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
9/30/2018
Total Revenue927610
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A10397141
Gross Profit-10-21-131
Selling, General and Administrative Excl. Other1421320
Research and Development112129158
Other Operating Expense0-1-47
Operating Income-265-281-241
Interest Expense45379
Unusual Expense
———
Non-Operating Income (Expense)-22-21-1
Net Income Before Taxes-289-297-219
Income Taxes1-92
Consolidated Net Income-289-288-221
Net Income From Continuing Operations-289-288-221
Net Income-289-288-221
EPS (Recurring)-1.09-1.08-0.87
EPS (Basic, Before Extraordinaries)-1.09-1.08-0.87
EPS (Diluted)-1.09-1.08-0.87
EBITDA-231-250-233
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio4.376.97—
Gross Margin-10.87-27.63-1,310.00
Operating Margin-288.04-369.74-2,410.00
Net Margin-314.13-378.95-2,210.00
Shares Outstanding266266255
Market Capitalization402529—
Operating Lease Expense
———
Insider Trading Volume
$1.65$1.52$1.40$1.28$1.15● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR